THC Therapeutics acquires The Headquarters Group in ~$11M all-stock deal

THC Therapeutics, Inc.

Acquired 100% of THG for 11,007 shares of new Series D Preferred stock, valued at ~$11M.
THG subsidiaries include Jefferson Soul, Kalix, NPK Industries, Harvest Food for Life, and real estate; combined 2024 revenue ~$4.8M.
Management cites 60+ years combined experience; plans vertical integration for growth in CA/OR cannabis markets.

item 1.01item 2.01item 3.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.